The hmp gene in P. putida is regulated by the σ54-dependent transcriptional activator FhpR, which responds to NO . Recombinant expression systems leverage:
Promoter Systems: Synthetic or inducible promoters (e.g., Ptac, Plac) to drive hmp expression .
Host Strains: Engineered P. putida KT2440 variants with enhanced metabolic vigor and reduced protease activity for high-yield production .
Recombinant Hmp has potential in:
Bioremediation: Degradation of nitrogen oxides in contaminated environments.
Industrial Biocatalysis: Protecting enzymes in aerobic bioprocesses from NO inhibition .
Synthetic Biology: Integration into microbial chassis for stress-resistant metabolic pathways .
NO Detoxification Efficiency: Recombinant P. putida expressing Hmp shows a 50% reduction in intracellular NO levels under microaerobic conditions .
Cross-Species Functionality: P. putida Hmp complements NO sensitivity in E. coli hmp mutants, confirming functional conservation .
Structural Insights: Crystal structures of homologous flavohemoglobins (e.g., PDB 1LVL) reveal conserved active-site residues critical for NO oxidation .
Note: We will prioritize shipping the format currently in stock. However, please specify any format requirements in your order notes, and we will accommodate your request to the best of our ability.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping is available upon request and incurs an additional charge. Please contact us in advance to arrange this.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
This flavohemoprotein participates in aerobic nitric oxide detoxification, specifically the nitric oxide dioxygenase (NOD) reaction. This reaction utilizes O2 and NAD(P)H to convert NO to nitrate, thus protecting the bacterium from harmful nitrogenous compounds. Consequently, this protein plays a crucial role in the inducible response to nitrosative stress.
KEGG: ppu:PP_0808
STRING: 160488.PP_0808
Recombinant Pseudomonas putida flavohemoprotein (hmp) is a genetically engineered variant of the flavohemoprotein enzyme expressed in the bacterium Pseudomonas putida. Flavohemoproteins are dual-function enzymes that contain both a flavin adenine dinucleotide (FAD)-binding domain and a heme-binding domain, enabling them to participate in redox reactions and nitric oxide detoxification. The significance of recombinant hmp lies in its applications in studying oxidative stress responses, bioremediation, and synthetic biology.
The use of Pseudomonas putida as a host organism for recombinant expression offers several advantages. This bacterium is highly adaptable, with a robust metabolism capable of tolerating xenobiotics and high oxidative stress. These properties make it an ideal chassis for producing recombinant proteins like hmp. Furthermore, hmp's ability to neutralize reactive nitrogen species (RNS) has implications for understanding microbial resistance mechanisms and developing biotechnological solutions for environmental challenges .
Experimental design for optimizing hmp expression involves several critical steps:
Selection of Promoters: The choice of promoter significantly influences the expression level of recombinant hmp. Inducible promoters such as the XylS/Pm system, which is activated by 3-methylbenzoate, allow controlled expression levels. Researchers must evaluate promoter strength using reporter assays like GFP fluorescence or enzymatic activity measurements .
Codon Optimization: Since codon usage varies among organisms, optimizing the hmp gene sequence to match the codon preferences of Pseudomonas putida can enhance translation efficiency.
Plasmid Vector Selection: Broad-host-range plasmids like pSEVA238 are commonly used for expressing recombinant proteins in Pseudomonas putida. These vectors should include features such as antibiotic resistance markers and multiple cloning sites .
Culture Conditions: Factors such as temperature, pH, and nutrient composition impact protein expression. For example, lower temperatures may reduce protein aggregation and improve solubility.
Induction Strategies: The timing and concentration of inducers like 3-methylbenzoate must be optimized to balance growth and protein production.
Analytical Techniques: Methods such as SDS-PAGE, Western blotting, and mass spectrometry are used to confirm protein expression and purity.
Table 1 summarizes key experimental parameters for optimizing hmp expression:
| Parameter | Recommended Approach |
|---|---|
| Promoter | XylS/Pm inducible system |
| Codon Optimization | Match codon usage to Pseudomonas putida |
| Vector | Broad-host-range plasmids (e.g., pSEVA238) |
| Temperature | 20-30°C |
| Inducer | 3-methylbenzoate (concentration-dependent) |
Purifying recombinant hmp involves overcoming several challenges:
Protein Solubility: Recombinant proteins often form inclusion bodies due to improper folding. This can be mitigated by co-expressing chaperones or lowering the culture temperature during expression .
Contaminants: The host's native proteins can co-purify with recombinant hmp, complicating downstream processes. Affinity chromatography using tags like His-tag or Strep-tag facilitates selective purification.
Stability: Flavohemoproteins are prone to oxidative damage due to their role in redox reactions. Adding reducing agents like dithiothreitol (DTT) during purification can preserve enzyme activity.
Yield Optimization: Achieving high yields requires balancing expression levels with cell viability. Overexpression can lead to metabolic burden and reduced growth rates.
Post-Translational Modifications: While rare in bacterial systems, post-translational modifications may affect protein function and require additional verification steps.
Researchers typically use a combination of chromatographic techniques—such as ion exchange, size exclusion, and affinity chromatography—to achieve high purity levels.
Nitric oxide (NO) plays a crucial role in regulating flavohemoprotein genes through NO-responsive transcriptional regulators such as FhpR in Pseudomonas aeruginosa. In Pseudomonas putida, similar regulatory mechanisms are hypothesized but not fully characterized .
The regulatory cascade involves the activation of σ54-dependent promoters by FhpR in response to NO or related reactive nitrogen species (RNS). This activation ensures that flavohemoproteins are expressed when cells encounter nitrosative stress conditions.
Experimental approaches to study NO regulation include:
Promoter Activity Assays: Reporter constructs with luciferase or GFP under the control of the fhp promoter can quantify NO-induced transcriptional activity.
Mutant Strains: Creating knockout strains deficient in key regulators like FhpR allows researchers to dissect their roles in gene regulation.
Electrophoretic Mobility Shift Assays (EMSAs): These assays confirm direct binding of regulatory proteins to fhp promoter sequences.
Quantitative PCR (qPCR): Measuring fhp mRNA levels under varying NO concentrations provides insights into transcriptional dynamics.
Understanding NO regulation has implications for microbial physiology and biotechnology applications, such as engineering bacteria for enhanced RNS detoxification .
To study the enzymatic activity of recombinant hmp, researchers employ various biochemical and biophysical techniques:
Spectrophotometric Assays: Flavohemoproteins exhibit characteristic absorbance spectra due to their heme groups. Monitoring changes in absorbance at specific wavelengths (e.g., 415 nm for Soret band) provides information about enzyme activity.
Nitric Oxide Scavenging Assays: These assays measure the ability of hmp to detoxify NO using NO-sensitive dyes or electrodes.
Oxygen Consumption Measurements: Flavohemoproteins catalyze oxygen-dependent reactions that can be monitored using oxygen-sensitive probes.
Kinetic Analysis: Determining parameters such as and using Michaelis-Menten kinetics helps characterize enzyme efficiency under different conditions.
Site-Directed Mutagenesis: Altering specific amino acids within the active site allows researchers to identify residues critical for catalysis.
Structural Studies: Techniques like X-ray crystallography or NMR spectroscopy reveal structural details that correlate with function.
These strategies provide comprehensive insights into hmp's catalytic mechanisms and potential applications .
Data contradictions often arise due to differences in experimental conditions or methodologies across studies. Resolving these discrepancies requires:
Standardization of Protocols: Ensuring consistent experimental conditions—such as pH, temperature, and substrate concentrations—reduces variability.
Replication Studies: Independent replication of experiments by different research groups validates findings.
Meta-Analysis: Combining data from multiple studies using statistical methods identifies overarching trends despite individual inconsistencies.
Advanced Analytical Tools: Techniques like mass spectrometry or high-throughput sequencing provide more precise measurements that clarify ambiguous results.
Hypothesis Testing: Designing experiments specifically aimed at testing conflicting hypotheses helps resolve uncertainties.
For example, discrepancies regarding NO detoxification efficiency may stem from variations in NO delivery methods or detection systems used across studies .